English Français

Medexus Pharmaceuticals, Inc. Medexus Pharmaceuticals, Inc.

  • English
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Business Development
  • Our Portfolio
    • Overview
    • Canadian Product Portfolio
    • US Product Portfolio
  • News
    • Press Releases
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Presentation
    • Financial Results
    • Stock Data
    • Governance
    • SEDAR+
  • Contact
  • Careers
  • English
  • Français

Press Releases

News

News

  • Press Releases
  • Events
Apr 18, 2023 5:30pm EDT

Medexus to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference

Apr 11, 2023 7:25am EDT

Medexus Expects Record Revenue for Fiscal Year 2023 and Provides Business Update

Mar 22, 2023 7:20am EDT

Medexus Announces New License Deal for Topical Terbinafine

Mar 08, 2023 5:00pm EST

Medexus Announces US$58.5 million in New Credit Facilities

Mar 06, 2023 8:00am EST

Medexus to Participate in 35th Annual Roth Conference

Feb 08, 2023 5:00pm EST

Medexus Announces Another Record Quarter with Fiscal Q3 2023 Revenue of US$28.7 Million, a 35% Increase Over Fiscal Q3 2022

Feb 06, 2023 5:00pm EST

Medexus Welcomes Two New Board Members

Feb 01, 2023 5:00pm EST

Medexus Secures Public Reimbursement for Cuvposa® in Quebec

Jan 31, 2023 5:00pm EST

Medexus Schedules Third Fiscal Quarter 2023 Conference Call

Jan 12, 2023 7:30am EST

Medexus Expects Record Revenue for Fiscal Q3 2023 and Provides Business Update

RSS
  • Previous
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...19
    Next
    © 2025 Medexus Pharmaceuticals, Inc.
    All Rights Reserved.
    Facebook Facebook
    Privacy Policy Disclaimer Sitemap

    Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.